Junrong Yan

1.4k total citations
72 papers, 920 citations indexed

About

Junrong Yan is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Junrong Yan has authored 72 papers receiving a total of 920 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Pulmonary and Respiratory Medicine, 24 papers in Oncology and 20 papers in Cancer Research. Recurrent topics in Junrong Yan's work include Lung Cancer Treatments and Mutations (20 papers), Cancer Genomics and Diagnostics (18 papers) and Monoclonal and Polyclonal Antibodies Research (7 papers). Junrong Yan is often cited by papers focused on Lung Cancer Treatments and Mutations (20 papers), Cancer Genomics and Diagnostics (18 papers) and Monoclonal and Polyclonal Antibodies Research (7 papers). Junrong Yan collaborates with scholars based in China, United States and United Kingdom. Junrong Yan's co-authors include Yakun Wan, Weijun Ou, Qin Wei, Xiang Ren, Dan Wu, Guanghui Li, Songqin Liu, Yang Shao, Yonghong Hu and Henan Li and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Analytical Chemistry.

In The Last Decade

Junrong Yan

58 papers receiving 909 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Junrong Yan China 16 495 218 204 190 152 72 920
Yingting Liu China 19 623 1.3× 176 0.8× 188 0.9× 519 2.7× 112 0.7× 81 1.7k
Zhihang Chen United States 19 511 1.0× 121 0.6× 249 1.2× 153 0.8× 223 1.5× 48 1.2k
Ziyi Yang China 20 553 1.1× 250 1.1× 122 0.6× 265 1.4× 273 1.8× 116 1.2k
Lingyun Huang China 21 459 0.9× 186 0.9× 318 1.6× 97 0.5× 123 0.8× 80 1.2k
Jiasheng Cao China 16 531 1.1× 257 1.2× 198 1.0× 401 2.1× 246 1.6× 53 1.3k
Desheng Hu China 19 253 0.5× 183 0.8× 80 0.4× 273 1.4× 198 1.3× 70 870
Wei Mo China 15 203 0.4× 39 0.2× 83 0.4× 81 0.4× 76 0.5× 91 830
Mengting Li China 15 428 0.9× 71 0.3× 88 0.4× 168 0.9× 143 0.9× 62 1.1k
Win Topatana China 13 455 0.9× 219 1.0× 213 1.0× 341 1.8× 204 1.3× 30 1.1k

Countries citing papers authored by Junrong Yan

Since Specialization
Citations

This map shows the geographic impact of Junrong Yan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junrong Yan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junrong Yan more than expected).

Fields of papers citing papers by Junrong Yan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junrong Yan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junrong Yan. The network helps show where Junrong Yan may publish in the future.

Co-authorship network of co-authors of Junrong Yan

This figure shows the co-authorship network connecting the top 25 collaborators of Junrong Yan. A scholar is included among the top collaborators of Junrong Yan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junrong Yan. Junrong Yan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Chengran, Yanling Feng, Xianfang Rong, et al.. (2025). Mesenchymal stromal cell exosomes for drug delivery of prostate cancer treatments: a review. Stem Cell Research & Therapy. 16(1). 18–18. 1 indexed citations
2.
3.
Guo, Fuyu, Shiwei Sun, Yue Wang, et al.. (2024). Predicting axillary lymph node metastasis in breast cancer using a multimodal radiomics and deep learning model. Frontiers in Immunology. 15. 1482020–1482020. 4 indexed citations
4.
5.
Yang, Yang, Tingting Feng, Changchun Wang, et al.. (2023). Genomic and Transcriptomic Remodeling by Neoadjuvant Chemoradiotherapy (nCRT) and the Indicative Role of Acquired INDEL Percentage for nCRT Efficacy in Esophageal Squamous Cell Carcinoma. International Journal of Radiation Oncology*Biology*Physics. 117(4). 979–993. 1 indexed citations
6.
Xu, Qi, Xiaoqing Xu, Junrong Yan, et al.. (2023). Exploring potential molecular resistance and clonal evolution in advanced HER2-positive gastric cancer under trastuzumab therapy. Oncogenesis. 12(1). 21–21. 9 indexed citations
7.
Fu, Junhui, et al.. (2022). Bile is a reliable and valuable source to study cfDNA in biliary tract cancers. Frontiers in Oncology. 12. 961939–961939. 8 indexed citations
8.
Liang, Jinxiao, Yinjie Wang, Lei Cai, et al.. (2022). Comparative Genomic Analysis Reveals Genetic Variations in Multiple Primary Esophageal Squamous Cell Carcinoma of Chinese Population. Frontiers in Oncology. 12. 868301–868301. 3 indexed citations
9.
Jin, Rui, Ling Peng, Jiawei Shou, et al.. (2021). EGFR-Mutated Squamous Cell Lung Cancer and Its Association With Outcomes. Frontiers in Oncology. 11. 680804–680804. 33 indexed citations
10.
Cai, Lei, Jiangfeng Wang, Junrong Yan, et al.. (2021). Genomic Profiling and Prognostic Value Analysis of Genetic Alterations in Chinese Resected Lung Cancer With Invasive Mucinous Adenocarcinoma. Frontiers in Oncology. 10. 603671–603671. 11 indexed citations
11.
Zhang, Shirong, Yang Xu, Pan Zhao, et al.. (2021). Integrated Analysis of Genomic and Immunological Features in Lung Adenocarcinoma With Micropapillary Component. Frontiers in Oncology. 11. 652193–652193. 15 indexed citations
12.
He, Qiong, Xian Lun Zhu, Xun Shi, et al.. (2020). cfDNA changes for monitoring of targeted therapy in a primary EGFR mutation lung adenocarcinoma. Translational Lung Cancer Research. 9(3). 807–810.
13.
Chen, Yao, Xiaochen Zhang, Qi Jiang, et al.. (2020). Lung adenocarcinoma with a novel SRBD1-ALK Fusion responding to crizotinib. Lung Cancer. 146. 370–372. 9 indexed citations
14.
Chen, Zhanhong, Tian Sun, Ziyan Yang, et al.. (2019). Monitoring treatment efficacy and resistance in breast cancer patients via circulating tumor DNA genomic profiling. Molecular Genetics & Genomic Medicine. 8(2). e1079–e1079. 25 indexed citations
15.
Song, Zhengbo, Zhijian Cai, Junrong Yan, Yang Shao, & Yiping Zhang. (2019). Liquid biopsies using pleural effusion-derived exosomal DNA in advanced lung adenocarcinoma. Translational Lung Cancer Research. 8(4). 392–400. 30 indexed citations
16.
Xu, Yanjun, Xiaoling Tong, Junrong Yan, et al.. (2018). Short-Term Responders of Non–Small Cell Lung Cancer Patients to EGFR Tyrosine Kinase Inhibitors Display High Prevalence of TP53 Mutations and Primary Resistance Mechanisms. Translational Oncology. 11(6). 1364–1369. 20 indexed citations
17.
Yan, Junrong, Guanghui Li, Yonghong Hu, Weijun Ou, & Yakun Wan. (2014). Construction of a synthetic phage-displayed Nanobody library with CDR3 regions randomized by trinucleotide cassettes for diagnostic applications. Journal of Translational Medicine. 12(1). 343–343. 88 indexed citations
18.
Li, Henan, Junrong Yan, Weijun Ou, et al.. (2014). Construction of a biotinylated cameloid-like antibody for lable-free detection of apolipoprotein B-100. Biosensors and Bioelectronics. 64. 111–118. 37 indexed citations
19.
Yan, Junrong & Xiaorong Xu. (2013). Performance Analysis for Split Phase Multi-Channel Protocols. International Review on Computers and Software (IRECOS). 8(1). 302–306.
20.
Yan, Junrong. (2011). Application of Multisim10 simulation in theory teaching of analog electronics technology course.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yingting Liu Breakdown of academic impact, for papers by Zhihang Chen Breakdown of academic impact, for papers by Ziyi Yang Breakdown of academic impact, for papers by Lingyun Huang Breakdown of academic impact, for papers by Jiasheng Cao Breakdown of academic impact, for papers by Desheng Hu Breakdown of academic impact, for papers by Wei Mo Breakdown of academic impact, for papers by Mengting Li Breakdown of academic impact, for papers by Win Topatana
Rankless by CCL
2026